Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neoadjuvant chemotherapy followed by debulking surgery and intraperitoneal hyperthermic chemotherapy for stage III ovarian cancer
2007-005674-31Phase 2Completed
- Sponsor
- Azienda Ospedaliera Universitaria Senese
- Start
- Nov 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of paclitaxel, cisplatin and mitomycin c in epithelial ovarian cancer (EOC) (2 arms), sponsored by Azienda Ospedaliera Universitaria Senese. Primary endpoint: Long-term results. Started Nov 2007; status: completed.
02
Drugs
paclitaxelcisplatinmitomycin c
03
Conditions
epithelial ovarian cancer (EOC)
Beyond the preview
Go deeper on 2007-005674-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-005674-31.